Small-batch research peptidesThird-party tested for purityDispatched within 24 hoursEvery lot on the recordFree US shipping over $15010% off your first orderFor research use only
Small-batch research peptidesThird-party tested for purityDispatched within 24 hoursEvery lot on the recordFree US shipping over $15010% off your first orderFor research use only
Tesamorelin
Also known as Tesamorlin · EGRIFTA · TH9507
Stabilized GHRH analog — A 44-amino-acid GHRH analog that stimulates pituitary GH secretion, studied for visceral adipose-tissue reduction in research.
Purity specification: 99%+Lyophilized powder
From $109.99In stock
View purchase options
Specifications
| CAS number | 218949-48-5 |
|---|
| Molecular formula | C221H366N72O67S |
|---|
| Molecular weight | 5135.86 g/mol |
|---|
| Form | Lyophilized powder |
|---|
Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or therapeutic purposes.
Documentation
Certificates of Analysis
Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.
No released lot-specific certificates are currently published for this compound. A certificate appears only after its batch clears release and the source PDF is available.
View the compound COA record →
Research context
Sources and references
How is tesamorelin characterized in research?
Tesamorelin is a stabilized growth-hormone-releasing-hormone analog. These references identify its research class and analytical context; they do not constitute directions for use or evidence about an Astral lot.
Analytical review
Memdouh S, Gavrilović I, Ng K, et al. Drug Testing and Analysis (2021).
Discusses identification and detection of synthetic GHRH analogs, including the analytical identity boundary.
PMID 34665524 · DOI 10.1002/dta.3183
Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-07-21. How sources are selected.
Read the compound research page →